We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Heat Biologics Inc | NASDAQ:HTBX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.83 | 2.81 | 2.89 | 0 | 01:00:00 |
H EAT B IOLOGICS , I NC .
801 C APITOLA D RIVE
D URHAM , NC 27713
November 22, 2017
VIA EDGAR
United States Securities
and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: |
Heat Biologics, Inc. Registration Statement on Form S-1 (File No. 333-220470) Request for Withdrawal |
Ladies and Gentlemen:
Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the Securities Act ), Heat Biologics, Inc. (the Company ) hereby respectfully requests that the Securities and Exchange Commission (the Commission ) consent to the withdrawal, effective as of the date hereof or at the earliest practicable date hereafter, of its Registration Statement on Form S-1 (File No. 333-220470), together with all exhibits thereto, initially filed on September 15, 2017, as subsequently amended on October 10, 2017 and October 17, 2017 (collectively, the Registration Statement ).
The Company is requesting to withdraw the Registration Statement because the rights offering contemplated by the Registration Statement has been terminated. The Company hereby confirms that the Registration Statement was declared effective by the Commission on October 19, 2017; however, no securities have been or will be sold pursuant to the Registration Statement.
The Company also requests that, in accordance with Rule 457(p) under the Securities Act, all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use.
If you have any questions or need additional information regarding the foregoing request for withdrawal, please do not hesitate to contact the Companys counsel, Leslie Marlow of Gracin & Marlow, LLP at (516) 496-2223 or (212) 907-6457.
|
|
|
Sincerely,
HEAT BIOLOGICS, INC. |
||
|
|
|
|
|
/s/ Jeff Wolf |
|
|
Jeff Wolf Chief Executive Officer |
1 Year Heat Biologics Chart |
1 Month Heat Biologics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions